Description
An inhibitor of prolyl hydroxylase; reduces levels of HIF-1α in rat liver and kidney; increases the expression of Epo, Fpn1, and Hamp in rat liver in a model of PGPS-induced anemia; increases plasma levels of erythropoietin in rats by 10.3- to 40-fold at 15 and 30 mg/kg, respectively; increases plasma levels of erythropoietin and hemoglobin, as well as the number of circulating red blood cells, in nephrectomized rats in a model of chronic kidney disease-induced anemia at 15 and 30 mg/kg
Formal name: N-[[1-(cyclopropylmethoxy)-1,2-dihydro-4-hydroxy-2-oxo-3-quinolinyl]carbonyl]-glycine
Synonyms:
Molecular weight: 332.3
CAS: 1616690-16-4
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors|Prolyl Hydroxylation Enzymes||Research Area|Cardiovascular System|Blood|Erythrocytes & Hemoglobin||Research Area|Cardiovascular System|Kidney & Renal Disease|Chronic Kidney Disease||Research Area|Epigenetics, Transcription, & Translation|Transcription Factors||Research Area|Immunology & Inflammation